In arthritis, the activation levels of ERK1/2 are often significantly increased, which may be associated with the proliferation of inflammatory cells, synthesis of inflammatory mediators, and damage to joint tissues (Marotte et al., 2010). This evidence concerns the gene MAPK3 and arthritic joint disease.